adipic acid has been researched along with Colorectal Neoplasms in 1 studies
adipic acid : An alpha,omega-dicarboxylic acid that is the 1,4-dicarboxy derivative of butane.
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jian, YS | 1 |
Chen, CW | 1 |
Lin, CA | 1 |
Yu, HP | 1 |
Lin, HY | 1 |
Liao, MY | 1 |
Wu, SH | 1 |
Lin, YF | 1 |
Lai, PS | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Phase 1,Two-part (Dose Escalation, Dose Expansion), Multicenter,Non-randomized,Open-label, Multiple Dose, First-in-human Study of CA102N Monotherapy and of CA102N Combined With Trifluridine/Tipiracil (LONSURF) in Subjects With Advanced Solid Tumors[NCT03616574] | Phase 1 | 37 participants (Actual) | Interventional | 2019-04-09 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for adipic acid and Colorectal Neoplasms
Article | Year |
---|---|
Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.
Topics: Adipates; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Colorectal N | 2017 |